# Macugen Observational Study

> **NCT00735943** · — · TERMINATED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Vascular Endothelial Growth Factor
- Macular Degeneration

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT00735943
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2011-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735943, "Macugen Observational Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00735943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*